Historically, several potentially Tn-bearing glycoproteins, including mucins CA15-3 (MUC1) and CA125 (MUC16), have been developed for clinical use in following cancer progression; however, the expression and identification of mucin protein epitopes are not specific enough for use in cancer screening [29–31]. The gene discussed is MUC16; the disease is cancer.